BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

NCT04932863 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Cancer, Treatment-Related

Interventions

BIOLOGICAL: BNT162b2 mRNA Covid-19 Vaccine

Sponsor

Ente Ospedaliero Ospedali Galliera

Collaborators

[object Object]